Market Tracker

12/02 12:58pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.55
BATS BZX Real-Time Price
As of 12:56pm ET
 -0.02 / -0.56%
Today’s Change
2.85
Today|||52-Week Range
18.31
-77.36%
Year-to-Date
The Worst Biotech Stocks of 2016
12:14pm / MotleyFool.com - Paid Partner Content
Ready to Get In on Biotech? Check Out These 3 Stocks
Nov 20 / MotleyFool.com - Paid Partner Content
Down 11.7%: Is Celldex Therapeutics Now a Buy?
Nov 29 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.57
Today’s open3.51
Day’s range3.51 - 3.73
Volume99,435
Average volume (3 months)2,373,920
Market cap$361.5M
Dividend yield--
Data as of 12:56pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.21

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...-0.15-1.00%
LNTHLantheus Holdings In...-0.10-1.09%
IMMUImmunomedics Inc+0.11+3.50%
VCYTVeracyte Inc-0.09-1.23%
Data as of 12:55pm ET, 12/02/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts